Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Barlocco

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Drug Discovery Today|April 13, 2001
NF-kappaB and AP-1 gene expression inhibitorsD Barrett, D Barlocco
Drug Discovery Today|September 8, 2001
Monitor: molecules and profilesS Langston, D Barlocco
Drug Discovery Today|March 21, 2001
Monitor: molecules and profilesS Langston, D Barlocco
Current Medicinal Chemistry|June 12, 2012
Designed multiple ligands: basic research vs clinical outcomesL Costantino, D Barlocco
Drug Discovery Today|September 29, 2001
Monitor: molecules and profilesM A. Walker, D Barlocco
Drug Discovery Today|March 27, 2001
Monitor: molecules and profilesM A. Walker, D Barlocco
Drug Discovery Today|July 11, 2001
Monitor: molecules and profilesS Langston, D Barlocco, D Tranter
Farmaco (Societa Chimica Italiana : 1989)|October 1, 1993
Synthesis and pharmacological evaluation of a new class of 2-oxo-8-azaspiro (4,5)decan-1-ones as analogues of the muscarinic agonist RS-86G Cignarella, S Villa, D Barlocco
Drug Discovery Today|February 22, 2001
Monitor: molecules and profilesD Barrett, D Barlocco, D Tranter
Farmaco (Societa Chimica Italiana : 1989)|March 1, 1993
Synthesis and opioid receptor affinity of bivalent ligands derived from 3,8-diazabicyclo(3.2.1)octanesD Barlocco, P Fadda, W Fratta
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Drug Discovery Today|April 13, 2001
NF-kappaB and AP-1 gene expression inhibitorsD Barrett, D Barlocco
Drug Discovery Today|September 8, 2001
Monitor: molecules and profilesS Langston, D Barlocco
Drug Discovery Today|March 21, 2001
Monitor: molecules and profilesS Langston, D Barlocco
Current Medicinal Chemistry|June 12, 2012
Designed multiple ligands: basic research vs clinical outcomesL Costantino, D Barlocco
Drug Discovery Today|September 29, 2001
Monitor: molecules and profilesM A. Walker, D Barlocco
Drug Discovery Today|March 27, 2001
Monitor: molecules and profilesM A. Walker, D Barlocco
Drug Discovery Today|July 11, 2001
Monitor: molecules and profilesS Langston, D Barlocco, D Tranter
Farmaco (Societa Chimica Italiana : 1989)|October 1, 1993
Synthesis and pharmacological evaluation of a new class of 2-oxo-8-azaspiro (4,5)decan-1-ones as analogues of the muscarinic agonist RS-86G Cignarella, S Villa, D Barlocco
Drug Discovery Today|February 22, 2001
Monitor: molecules and profilesD Barrett, D Barlocco, D Tranter
Farmaco (Societa Chimica Italiana : 1989)|March 1, 1993
Synthesis and opioid receptor affinity of bivalent ligands derived from 3,8-diazabicyclo(3.2.1)octanesD Barlocco, P Fadda, W Fratta
Pageof 7